Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
The estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses are frequently discordant between the primary tumor and metastatic lesions in metastatic breast cancer. This can have important therapeutic implications.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
01 July 2020
|
| In: |
Breast cancer research and treatment
Year: 2020, Jahrgang: 183, Heft: 1, Pages: 137-144 |
| ISSN: | 1573-7217 |
| DOI: | 10.1007/s10549-020-05746-8 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10549-020-05746-8 |
| Verfasserangaben: | Vincent Walter, Chiara Fischer, Thomas M. Deutsch, Catherine Ersing, Juliane Nees, Florian Schütz, Carlo Fremd, Eva-Maria Grischke, Peter Sinn, Sara Y. Brucker, Andreas Schneeweiss, Andreas D. Hartkopf, Markus Wallwiener |
| Zusammenfassung: | The estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses are frequently discordant between the primary tumor and metastatic lesions in metastatic breast cancer. This can have important therapeutic implications. |
|---|---|
| Beschreibung: | Gesehen am 08.12.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1573-7217 |
| DOI: | 10.1007/s10549-020-05746-8 |